Alclometasone
| 220px | |
| Alclometasone
| |
| Systematic (IUPAC) name | |
| [7-chloro-11-hydroxy- 10,13,16-trimethyl-3-oxo-17- (2-propanoyloxyacetyl)- 7,8,9,11,12, 14,15,16- octahydro-6H-cyclopenta[a]phenanthren-17-yl] propanoate | |
| Identifiers | |
| CAS number | |
| ATC code | D07 S01BA10 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C28H37ClO7 |
| Mol. mass | 521.042 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | topical |
Contents |
Description
Alclometasone is synthetic glucocorticoid steroid for topical use in dermatology as anti-inflammatory, antipruritic, antiallergic, antiproliferative and vasoconstrictive agent.
Alclometasone Dipropionate marketed as medication Aclovate by GlaxoSmithKline.
Pharmacology
Alclometasone inhibits phospholipase A2 by inducing production of lipocortins;
inhibits synthesis of arachidonic acid, prostaglandins and leukotrienes acid,
reduce release of cytokines from lymphocytes and others mediators of inflammation (incl. histamine).
Indications
Alclometasone cream and onintment are indicated for the relief of corticosteroid-responsive dermatoses, including:
Alclometasone may be used on sensetive skin sites (face, skinfolds); in pediatric patients 1 year or older and in geriatric patients.
Contraindications
Side effects
Alclometasone Adverse reactions/Side effects (sometimes, less than 1-2% cases) include:
How supplied
Alclometasone as Aclovate® is supplied in:
External links
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies